Holen Sie sich die Stockscreener-App
127.68
3.04%
4.07
Handel nachbörslich:
128.04
0.36
+0.28%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Merck Co Inc Aktie (MRK) Neueste Nachrichten
FDA Approval Adds New Cholesterol Treatment Option in Merck Portfolio - Benzinga
Merck & Co Inc Stock (MRK) Moved Up by 3.24% on Jul 16: Drivers Behind the Movement - TradingKey
Merck's cholesterol pill gets US FDA approval - Reuters
Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer - Benzinga
Autoimmune Disease Therapeutics Market Size to Reach USD 137.85 Billion by 2035 as Biologics and Precision Medicine Drive Growth | SNS Insider - GlobeNewswire Inc.
Merck & Co Inc Stock (MRK) Moved Up by 3.05% on Jul 15: Key Drivers Unveiled - TradingKey
Earnings preview: What to expect from Merck & Co.'s report - MSN
Earnings Preview: What To Expect From Merck & Co.'s Report - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
BMO Capital Adjusts Price Target on Merck & Co to $142 From $135, Maintains Outperform Rating - marketscreener.com
Why Merck Stock Is in the Spotlight Today - Benzinga
Merck stock holds steady after a research update - ad-hoc-news.de
Merck stock holds steady as analysts assess its pipeline - ad-hoc-news.de
Merck (MRK) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Merck & Co. Inc. stock underperforms Friday when compared to competitors - MarketWatch
Merck & Co. stock holds steady as a big pharma mainstay in the S&P 500 - ad-hoc-news.de
Merck & Co. stock holds steady as oncology and vaccines underpin long-term growth - AD HOC NEWS
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Merck & Co. Inc. updates its oncology pipeline as a major S&P 500 healthcare player - AD HOC NEWS
Merck & Co. focuses on oncology and vaccines as a major global pharma player - Ad-hoc-news.de
Former Merck and NASA Veterans Join SpaceMD as Space Pharma Momentum Builds - IPO Edge
Merck & Co. Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Merck & Co. highlights oncology pipeline progress as S&P 500 healthcare heavyweight. Longer-term gro - Ad-hoc-news.de
Merck To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
Merck & Co. focuses on oncology pipeline as investors watch long-term growth - Ad-hoc-news.de
Merck & Co. Inc. balances pharmaceuticals growth and pipeline investment - Ad-hoc-news.de
Merck & Co (MRK) BofA Securities 2025 Healthcare Conference Summary - Quartr
Merck & Co. highlights its pharmaceutical portfolio as investors track long-term growth prospects - AD HOC NEWS
Merck & Co. Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Merck & Co. highlights its pharmaceuticals strength as investors track long term growth - AD HOC NEWS
Merck & Co. highlights its pharmaceutical portfolio as a major global healthcare player - AD HOC NEWS
Merck & Co. looks to long-term growth as a global pharmaceutical leader - AD HOC NEWS
Merck (MRK) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance
Merck & Co. Inc. stock underperforms Monday when compared to competitors - MarketWatch
Merck & Co. focuses on oncology and vaccines as investors watch long-term growth - AD HOC NEWS
HSBC Adjusts Price Target on Merck & Co to $150 From $135 - Moomoo
Rothschild & Co Redburn Adjusts Price Target on Merck to $145 From $140 - Moomoo
Merck & Company, Inc. (MRK): Investor Outlook with a 2.62% Dividend Yield and Robust Buy Ratings - DirectorsTalk Interviews
Enterprise value to revenue forward of Merck & Co., Inc. – BX:6MK - TradingView
Redwood Grove Capital, LLC's Merck & Co Inc(MRK) Holding History - GuruFocus
ETFs Investing in Merck & Co., Inc. Stocks - TradingView
Merck & Co Inc (MRK) Shares Surge 3.3% -- What GF Score of 78 Te - GuruFocus
Merck & Co. Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Merck & Co Inc Stock (MRK) Closed Up by 3.16% on Jul 2: What Signal Does It Send? - TradingKey
Merck's Post-Keytruda Playbook Is Working, But Valuation Has Caught Up (NYSE:MRK) - Seeking Alpha
MRKMerck & Co Inc Volatility & Greeks - Finviz
Merck & Co. focuses on long-term growth as a global healthcare leader - AD HOC NEWS
Merck to Hold Second-Quarter 2026 Sales and Earnings Conference Call Aug. 4 - BioSpace
Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director Seidman Christine E - Moomoo
Merck (NYSE: MRK) director granted phantom stock in deferred pay plan - Stock Titan
Merck's Lung Cancer Drug Seen Boosting Sales Potential, BofA Says - Moomoo
Merck & Co earnings guidance frames 2026 outlook. Technicals show MRK trading in a tight range - AD HOC NEWS
Merck, AbbVie probed by US lawmakers over China clinical trials: report - Proactive financial news
1.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):